Lee Ainslie West Pharmaceutical Services Inc Transaction History

Maverick Capital LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$338.27 - $413.0 $336,240 - $410,522	994 New	994 $393,000
Q4 2021 Feb 14, 2022	SELL	$402.25 - $471.34 $661,701 - $775,354	-1,645 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$363.01 - $468.47 $565,569 - $729,876	1,558 Added 1790.8%	1,645 $698,000
Q2 2021 Aug 16, 2021	BUY	$284.77 - $363.2 $24,774 - $31,598	87 New	87 $31,000
Q2 2019 Aug 14, 2019	SELL	$111.27 - $125.15 $10.9 Million - $12.3 Million	-98,230 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$94.53 - $110.2 $162,591 - $189,544	-1,720 Reduced 1.72%	98,230 $10.8 Million
Q4 2018 Feb 14, 2019	BUY	$93.0 - $123.98 $5.37 Million - $7.16 Million	57,790 Added 137.07%	99,950 $9.8 Million
Q3 2018 Nov 14, 2018	BUY	$98.01 - $123.47 $4.13 Million - $5.21 Million	42,160 New	42,160 $5.21 Million

802

64.4M

294K

490K

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $23.3B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.